Parkinsonics: A Controlled Study of Group Singing in Parkinson Disease
Parkinsonics
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
The overall objective of this study is to observe the effect of group Vocal performance training and performance experience on patients' reported symptoms and quality of life. The effectiveness of PD medications varies significantly in different patients depending on their symptoms. By using music-based interventions to improve symptoms that may be inadequately treated by medications, the investigators hope to improve quality of life in PD patients. "Parkinsonics: A controlled study of group singing for quality of life and voice outcomes in Parkinson disease" (PD) is a controlled crossover behavioral intervention study of once weekly choral classes for patients with idiopathic PD (progressing toward a group performance) and once weekly discussion/support group meetings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 parkinson-disease
Started Dec 2015
Shorter than P25 for phase_2 parkinson-disease
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 25, 2016
CompletedFirst Posted
Study publicly available on registry
April 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2016
CompletedMarch 1, 2017
February 1, 2017
10 months
April 25, 2016
February 28, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Parkinson Disease Quality of Life Questionnaire (PDQ)-39 scores
Validated 39-item questionnaire
Change from baseline scores at 30 weeks
Secondary Outcomes (10)
Voice-Related Quality of Life
Change from baseline scores at 30 weeks
Movement Disorder Society-Unified Parkinson Disease Rating Scale Motor scores
Change from baseline scores at 30 weeks
Montreal Cognitive Assessment
Change from baseline scores at 30 weeks
Geriatric Depression Scale-15
Change from baseline scores at 30 weeks
Lorig Self-efficacy scale
Change from baseline scores at 30 weeks
- +5 more secondary outcomes
Other Outcomes (1)
Feasibility
12 weeks
Study Arms (2)
Singing Intervention
EXPERIMENTALTwelve weekly group singing classes lasting 60-90 minutes under the direction of a professional choir director and a social worker with a music background.
Discussion/Support Group Intervention
ACTIVE COMPARATORTwelve weekly 60-90 minute discussion groups led by a facilitator trained in discussion group facilitation; occurring at the same time and in the same location (next door) as experimental intervention (group singing).
Interventions
Weekly group singing classes led by professional choir instructor, lasting 90 minutes. 12 classes over 12 consecutive weeks.
Weekly facilitated discussion group led by Parkinson Disease educator, lasting 90 minutes. 12 sessions over 12 consecutive weeks.
Eligibility Criteria
You may qualify if:
- Diagnosis of idiopathic PD based on UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria for PD (Hughes et al. 1992).
You may not qualify if:
- Patients unable to consent to the study.
- Patients unable or unwilling to participate in weekly singing classes for 12 weeks, or unwilling to perform in a concert setting.
- Patients with active psychiatric disturbances (agitation, active hallucinations).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Pantelyat, MD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology
Study Record Dates
First Submitted
April 25, 2016
First Posted
April 28, 2016
Study Start
December 1, 2015
Primary Completion
October 1, 2016
Study Completion
December 31, 2016
Last Updated
March 1, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share